glp-1 market news november 2025 Shortage = Over GLP-1 Pharmacy Pricing Update (Dec

Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice

Although research on KPV is less extensive in this domain, its capacity to attenuate expression of chemokines and inflammatory mediators in immune cells suggests it may act synergistically with other peptides to suppress gene signatures linked to sustained inflammatory activation (30)

GLP-1 agonist shortage will last until end of 2024, government warns

E.FernandesT

Our AI advisor helps you determine if you're a candidate for aggressive protocols or if safer alternatives are better suited